Box–Behnken Design-Assisted Formulation of Apremilast-Loaded Niosomes: Characterization and In Vitro Evaluation for Targeted Management of Psoriatic Arthritis
Journal of Pharmaceutical Innovation · 2026-08 · 21 (4)
DOI: 10.1007/s12247-026-10644-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 11.04.2026. Verfasst von Sonam M. Gandhi und 1 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gandhi, S. M., & Dedania, R. (2026). Box–Behnken Design-Assisted Formulation of Apremilast-Loaded Niosomes: Characterization and In Vitro Evaluation for Targeted Management of Psoriatic Arthritis. Journal of Pharmaceutical Innovation, 21(4). https://doi.org/10.1007/s12247-026-10644-5
Vancouver
Gandhi SM, Dedania R. Box–Behnken Design-Assisted Formulation of Apremilast-Loaded Niosomes: Characterization and In Vitro Evaluation for Targeted Management of Psoriatic Arthritis. Journal of Pharmaceutical Innovation. 2026;21(4). doi:10.1007/s12247-026-10644-5
BibTeX
@article{Gandhi2026,
author = {Gandhi, Sonam M. and Dedania, Ronak},
title = {Box–Behnken Design-Assisted Formulation of Apremilast-Loaded Niosomes: Characterization and In Vitro Evaluation for Targeted Management of Psoriatic Arthritis},
journal = {Journal of Pharmaceutical Innovation},
year = {2026},
volume = {21},
number = {4},
doi = {10.1007/s12247-026-10644-5}
}
EUVIMED